Covid 19 in patients with systemic inflammatory diseases: impact on disease activity.
Current rheumatology reviews(2023)
摘要
Although our patients interrupted their DMARDs, our study demonstrates that disease activity as assessed by ASDAS and DAS28 in SpA and RA remained unchanged after COVID-19.
更多查看译文
关键词
Ankylosing Spondylitis Disease,COVID-19,Disease activity,Methotrexate,Systemic inflammatory diseases,rheumatic diseases
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要